ClearPoint Neuro, Inc. (CLPT) vs Pacific Biosciences of California, Inc. (PACB)
ClearPoint Neuro, Inc. and Pacific Biosciences of California, Inc. are both Medical Devices companies. ClearPoint Neuro, Inc. and Pacific Biosciences of California, Inc. are of similar size ($484.9M and $445.7M). ClearPoint Neuro, Inc. grew revenue faster over the last twelve months: 25.9% against 2.02%. ClearPoint Neuro, Inc. has the higher net margin (−81.8% vs −82.5%) and the lower return on invested capital (−61.3% vs −22.2%). Across the 17 metrics below, ClearPoint Neuro, Inc. leads on 9 and Pacific Biosciences of California, Inc. on 8.
Valuation
Profitability
| Metric | CLPT | PACB | Medical Devices median |
|---|---|---|---|
| Gross margin | 62.61% | 36.38% | 56.01% |
| Operating margin | (73.42%) | (83.53%) | (15.03%) |
| Net margin | (81.76%) | (82.49%) | (20.40%) |
| Free cash flow margin | (74.01%) | (50.53%) | (7.24%) |
| Return on equity | (226.52%) | (929.31%) | (15.32%) |
| Return on assets | (46.21%) | (16.66%) | (19.72%) |
| Return on invested capital | (61.31%) | (22.22%) | (10.33%) |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack